Antel, J., & Banaschewski, T. (2015). Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: Do we need a SCOUT (trial)? European archives of psychiatry and clinical neuroscience, 265(3), . https://doi.org/10.1007/s00406-014-0522-8
Chicago-Zitierstil (17. Ausg.)Antel, Jochen, und Tobias Banaschewski. "Assessment of Potential Cardiovascular Risks of Methylphenidate in Comparison with Sibutramine: Do We Need a SCOUT (trial)?" European Archives of Psychiatry and Clinical Neuroscience 265, no. 3 (2015). https://doi.org/10.1007/s00406-014-0522-8.
MLA-Zitierstil (9. Ausg.)Antel, Jochen, und Tobias Banaschewski. "Assessment of Potential Cardiovascular Risks of Methylphenidate in Comparison with Sibutramine: Do We Need a SCOUT (trial)?" European Archives of Psychiatry and Clinical Neuroscience, vol. 265, no. 3, 2015, https://doi.org/10.1007/s00406-014-0522-8.